Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Dromer

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|February 2, 2006
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?C Charlier, E Hart, A Lefort, et al.
Revue D'Epidemiologie Et De Sante Publique|October 2, 2012
Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative dataD Bitar, G Morizot, D Van Cauteren, et al.
The Journal of Infectious Diseases|December 9, 2000
Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatusO Lortholary, F Dromer, S Mathoulin-Pélissier, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosisE Dannaoui, M Abdul, M Arpin, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timingO Lortholary, M Nicolas, S Soreda, et al.
Journal of Clinical Microbiology|December 1, 1995
Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unitE Bart-Delabesse, H van Deventer, W Goessens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)F Lanternier, E Dannaoui, G Morizot, et al.
Journal of Clinical Microbiology|August 19, 2007
Peritonitis due to Blastobotrys proliferans in a patient undergoing continuous ambulatory peritoneal dialysisN Quirin, M Desnos-Ollivier, J F Cantin, et al.
Journal of Travel Medicine|March 26, 2003
An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West IndiesJ Salomon, M Flament Saillour, P De Truchis, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006E Dannaoui, O Lortholary, D Raoux, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|February 2, 2006
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?C Charlier, E Hart, A Lefort, et al.
Revue D'Epidemiologie Et De Sante Publique|October 2, 2012
Estimating the burden of mucormycosis infections in France (2005-2007) through a capture-recapture method on laboratory and administrative dataD Bitar, G Morizot, D Van Cauteren, et al.
The Journal of Infectious Diseases|December 9, 2000
Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatusO Lortholary, F Dromer, S Mathoulin-Pélissier, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosisE Dannaoui, M Abdul, M Arpin, et al.
The Journal of Antimicrobial Chemotherapy|July 15, 1999
Fluconazole, with or without dexamethasone for experimental cryptococcosis: impact of treatment timingO Lortholary, M Nicolas, S Soreda, et al.
Journal of Clinical Microbiology|December 1, 1995
Contribution of molecular typing methods and antifungal susceptibility testing to the study of a candidemia cluster in a burn care unitE Bart-Delabesse, H van Deventer, W Goessens, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2012
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007)F Lanternier, E Dannaoui, G Morizot, et al.
Journal of Clinical Microbiology|August 19, 2007
Peritonitis due to Blastobotrys proliferans in a patient undergoing continuous ambulatory peritoneal dialysisN Quirin, M Desnos-Ollivier, J F Cantin, et al.
Journal of Travel Medicine|March 26, 2003
An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West IndiesJ Salomon, M Flament Saillour, P De Truchis, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2007
Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006E Dannaoui, O Lortholary, D Raoux, et al.
Pageof 6